Clinical Trials
8
Active:2
Completed:5
Trial Phases
3 Phases
Phase 1:1
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (33.3%)Phase 2
1 (33.3%)Phase 3
1 (33.3%)Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque Psoriasis
Phase 3
Withdrawn
- Conditions
- Plaque Psoriasis
- Interventions
- First Posted Date
- 2013-03-21
- Last Posted Date
- 2016-08-09
- Lead Sponsor
- Forward-Pharma GmbH
- Registration Number
- NCT01815723
- Locations
- 🇨🇦
Probity Medical Research, Waterloo, Ontario, Canada
Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis
Phase 2
Completed
- Conditions
- Plaque Psoriasis
- Interventions
- Drug: FP187Drug: Placebo
- First Posted Date
- 2010-10-28
- Last Posted Date
- 2012-12-11
- Lead Sponsor
- Forward-Pharma GmbH
- Target Recruit Count
- 252
- Registration Number
- NCT01230138
- Locations
- 🇩🇪
Dermatological Dept., Uniklinikum, TU-Dresden, Dresden, Germany
🇩🇪SCIderm, Hamburg, Germany
News
No news found